Gary Patou
Insider
First SEC filing: June 8, 2026 · Latest: June 8, 2026
Insider at
Insider transactions
0 buys (P)
1 sells (S)
Net: $-70,251
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 5, 2026 | XENE | S 10b5-1 | 1,322 | $53.14 | $70,251 | 24,896 Direct | -5.04% | Disposed | -28.5% (price as of 2026-10-02) |
| June 3, 2026 | XENE | A | 1,593 | · | · | 1,593 Direct | · | Acquired | (price as of 2026-10-02) |
| June 3, 2026 | XENE | A | 10,507 | · | · | 10,507 Direct | · | Acquired | (price as of 2026-10-02) |
| June 1, 2026 | XENE | M | 2,645 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 1, 2026 | XENE | M | 2,645 | · | · | 26,218 Direct | +11.22% | Acquired | (price as of 2026-10-02) |
| June 5, 2025 | XENE | A | 2,645 | · | · | 2,645 Direct | · | Acquired | (price as of 2026-10-02) |
| June 5, 2025 | XENE | A | 17,012 | · | · | 17,012 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 22, 2024 | XENE | M | 3,086 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Nov. 22, 2024 | XENE | M | 3,500 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Nov. 22, 2024 | XENE | S | 2,040 | $41.05 | $83,742 | 23,573 Direct | -7.96% | Disposed | -7.4% (price as of 2026-10-02) |
| Nov. 22, 2024 | XENE | F | 1,046 | $39.80 | $41,631 | 25,613 Direct | -3.92% | Disposed | -4.5% (price as of 2026-10-02) |
| Nov. 22, 2024 | XENE | M | 3,086 | $13.48 | $41,599 | 26,659 Direct | +13.09% | Acquired | 182.0% (price as of 2026-10-02) |
| Nov. 22, 2024 | XENE | S | 2,851 | $41.11 | $117,205 | 23,573 Direct | -10.79% | Disposed | -7.5% (price as of 2026-10-02) |
| Nov. 22, 2024 | XENE | F | 649 | $39.80 | $25,830 | 26,424 Direct | -2.40% | Disposed | -4.5% (price as of 2026-10-02) |
| Nov. 22, 2024 | XENE | M | 3,500 | $7.38 | $25,830 | 27,073 Direct | +14.85% | Acquired | 415.2% (price as of 2026-10-02) |
| June 5, 2024 | XENE | A | 15,542 | · | · | 15,542 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 14, 2023 | XENE | S | 7,598 | $41.05 | $311,898 | 4,902 Indirect | -60.78% | Disposed | -7.4% (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | M | 5,144 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | M | 2,800 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | M | 6,378 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | S | 7,598 | $41.05 | $311,898 | 4,902 Indirect | -60.78% | Disposed | -7.4% (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | S | 3,977 | $39.84 | $158,444 | 23,573 Direct | -14.44% | Disposed | -4.6% (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | F | 1,167 | $39.68 | $46,307 | 27,550 Direct | -4.06% | Disposed | -4.2% (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | M | 5,144 | $9.00 | $46,296 | 28,717 Direct | +21.82% | Acquired | 322.4% (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | S | 2,303 | $39.10 | $90,047 | 23,573 Direct | -8.90% | Disposed | -2.8% (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | F | 577 | $39.68 | $22,895 | 25,876 Direct | -2.18% | Disposed | -4.2% (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | M | 2,880 | $9.85 | $28,368 | 26,453 Direct | +12.22% | Acquired | 286.0% (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | S | 5,100 | $38.94 | $198,594 | 23,573 Direct | -17.79% | Disposed | -2.4% (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | F | 1,278 | $39.68 | $50,711 | 28,673 Direct | -4.27% | Disposed | -4.2% (price as of 2026-10-02) |
| Dec. 13, 2023 | XENE | M | 6,378 | $9.85 | $62,823 | 29,951 Direct | +27.06% | Acquired | 286.0% (price as of 2026-10-02) |
| June 2, 2023 | XENE | A | 18,475 | · | · | 18,475 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 25, 2022 | XENE | M | 2,057 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Nov. 25, 2022 | XENE | S | 1,937 | $34.79 | $67,388 | 23,573 Direct | -7.59% | Disposed | 9.3% (price as of 2026-10-02) |
| Nov. 25, 2022 | XENE | F | 120 | $34.37 | $4,124 | 25,510 Direct | -0.47% | Disposed | 10.6% (price as of 2026-10-02) |
| Nov. 25, 2022 | XENE | M | 2,057 | $2.68 | $5,513 | 25,630 Direct | +8.73% | Acquired | 1318.7% (price as of 2026-10-02) |
| Nov. 23, 2022 | XENE | S | 2,057 | $34.33 | $70,617 | 23,573 Direct | -8.03% | Disposed | 10.7% (price as of 2026-10-02) |
| June 28, 2022 | XENE | A | 18,000 | · | · | 18,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 8, 2021 | XENE | M | 2,057 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Dec. 8, 2021 | XENE | M | 2,057 | $3.67 | $7,549 | 25,630 Direct | +8.73% | Acquired | 936.0% (price as of 2026-10-02) |
| June 3, 2021 | XENE | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| March 17, 2021 | XENE | L | 100 | $19.49 | $1,949 | 100 Indirect | · | Acquired | 95.1% (price as of 2026-10-02) |
| Oct. 28, 2020 | XENE | M | 2,057 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Oct. 28, 2020 | XENE | M | 2,057 | $3.76 | $7,734 | 23,573 Direct | +9.56% | Acquired | 911.2% (price as of 2026-10-02) |
| June 1, 2020 | XENE | A | 10,000 | · | · | 10,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 4, 2019 | XENE | M | 2,057 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Dec. 4, 2019 | XENE | M | 2,057 | $3.56 | $7,323 | 21,516 Direct | +10.57% | Acquired | 968.0% (price as of 2026-10-02) |
| Sept. 16, 2019 | XENE | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 14, 2018 | XENE | M | 2,057 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Dec. 14, 2018 | XENE | M | 2,057 | $3.07 | $6,315 | 19,459 Direct | +11.82% | Acquired | 1138.4% (price as of 2026-10-02) |
| June 14, 2018 | XENE | M | 8,230 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| June 14, 2018 | XENE | F | 2,856 | $8.30 | $23,705 | 17,402 Direct | -14.10% | Disposed | 358.1% (price as of 2026-10-02) |
| June 14, 2018 | XENE | M | 8,230 | $3.70 | $30,451 | 20,258 Direct | +68.42% | Acquired | 927.6% (price as of 2026-10-02) |
| June 4, 2018 | XENE | A | 15,000 | · | · | 15,000 Direct | · | Acquired | (price as of 2026-10-02) |
| Aug. 10, 2017 | XENE | P | 7,500 | $2.78 | $20,850 | 12,500 Indirect | +150.00% | Acquired | 1267.6% (price as of 2026-10-02) |
| Aug. 8, 2017 | XENE | P | 5,000 | $3.00 | $15,000 | 5,000 Indirect | · | Acquired | 1167.3% (price as of 2026-10-02) |
| June 1, 2017 | XENE | A | 3,500 | · | · | 3,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Dec. 6, 2016 | XENE | M | 12,345 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Dec. 6, 2016 | XENE | F | 4,403 | $7.90 | $34,784 | 12,028 Direct | -26.80% | Disposed | 381.3% (price as of 2026-10-02) |
| Dec. 6, 2016 | XENE | M | 12,345 | $3.21 | $39,627 | 16,431 Direct | +302.13% | Acquired | 1084.4% (price as of 2026-10-02) |
| June 2, 2016 | XENE | A | 3,500 | · | · | 3,500 Direct | · | Acquired | (price as of 2026-10-02) |
| Nov. 4, 2015 | XENE | M | 3,497 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Nov. 4, 2015 | XENE | F | 1,955 | $8.32 | $16,266 | 4,086 Direct | -32.36% | Disposed | 357.0% (price as of 2026-10-02) |
| Nov. 4, 2015 | XENE | M | 3,497 | $5.22 | $18,254 | 6,041 Direct | +137.46% | Acquired | 628.4% (price as of 2026-10-02) |
| May 4, 2015 | XENE | A | 3,086 | · | · | 3,086 Direct | · | Acquired | (price as of 2026-10-02) |
| Jan. 7, 2015 | XENE | M | 3,497 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
| Jan. 7, 2015 | XENE | M | 3,497 | $4.98 | $17,415 | 3,497 Direct | · | Acquired | 663.5% (price as of 2026-10-02) |
| Aug. 7, 2014 | PCRX | M 10b5-1 | 3,524 | · | · | 56,476 Direct | -5.87% | Disposed | (price as of 2026-10-02) |
| Aug. 7, 2014 | PCRX | M 10b5-1 | 14,364 | · | · | 18,333 Direct | -43.93% | Disposed | (price as of 2026-10-02) |
| Aug. 7, 2014 | PCRX | M 10b5-1 | 882 | · | · | 4,414 Direct | -16.65% | Disposed | (price as of 2026-10-02) |
| Aug. 7, 2014 | PCRX | M 10b5-1 | 1,230 | · | · | 1,230 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| Aug. 7, 2014 | PCRX | S 10b5-1 | 20,000 | $100.26 | $2,005,200 | 0 Direct | -100.00% | Disposed | -74.9% (price as of 2026-10-02) |
| Aug. 7, 2014 | PCRX | M 10b5-1 | 3,524 | $11.68 | $41,160 | 20,000 Direct | +21.39% | Acquired | 115.8% (price as of 2026-10-02) |
| Aug. 7, 2014 | PCRX | M 10b5-1 | 14,364 | $10.81 | $155,275 | 16,476 Direct | +680.11% | Acquired | 133.2% (price as of 2026-10-02) |
| Aug. 7, 2014 | PCRX | M 10b5-1 | 882 | $5.49 | $4,842 | 2,112 Direct | +71.71% | Acquired | 359.2% (price as of 2026-10-02) |
| Aug. 7, 2014 | PCRX | M 10b5-1 | 1,230 | $1.61 | $1,980 | 1,230 Direct | · | Acquired | 1465.8% (price as of 2026-10-02) |
| July 14, 2014 | PCRX | M 10b5-1 | 7,303 | · | · | 32,697 Direct | -18.26% | Disposed | (price as of 2026-10-02) |
| July 14, 2014 | PCRX | M 10b5-1 | 20,237 | · | · | 5,296 Direct | -79.26% | Disposed | (price as of 2026-10-02) |
| July 14, 2014 | PCRX | M 10b5-1 | 2,460 | · | · | 2,460 Direct | -50.00% | Disposed | (price as of 2026-10-02) |
| July 14, 2014 | PCRX | S 10b5-1 | 2,107 | $87.58 | $184,531 | 0 Direct | -100.00% | Disposed | -71.2% (price as of 2026-10-02) |
| July 14, 2014 | PCRX | S 10b5-1 | 27,593 | $86.91 | $2,398,108 | 2,407 Direct | -91.98% | Disposed | -71.0% (price as of 2026-10-02) |
| July 14, 2014 | PCRX | M 10b5-1 | 7,303 | $10.81 | $78,945 | 30,000 Direct | +32.18% | Acquired | 133.2% (price as of 2026-10-02) |
| July 14, 2014 | PCRX | M 10b5-1 | 20,237 | $5.49 | $111,101 | 22,697 Direct | +822.64% | Acquired | 359.2% (price as of 2026-10-02) |
| July 14, 2014 | PCRX | M 10b5-1 | 2,460 | $1.61 | $3,961 | 2,460 Direct | · | Acquired | 1465.8% (price as of 2026-10-02) |
| June 3, 2014 | PCRX | A | 25,000 | · | · | 25,000 Direct | · | Acquired | (price as of 2026-10-02) |
| May 12, 2014 | PCRX | M | 10,000 | · | · | 25,532 Direct | -28.14% | Disposed | (price as of 2026-10-02) |
| May 12, 2014 | PCRX | S 10b5-1 | 10,000 | $75.00 | $750,000 | 0 Direct | -100.00% | Disposed | -66.4% (price as of 2026-10-02) |
| May 12, 2014 | PCRX | M | 10,000 | $5.49 | $54,900 | 10,000 Direct | · | Acquired | 359.2% (price as of 2026-10-02) |
| May 9, 2014 | PCRX | M | 6,836 | · | · | 35,532 Direct | -16.13% | Disposed | (price as of 2026-10-02) |
| May 9, 2014 | PCRX | M | 13,164 | · | · | 4,920 Direct | -72.79% | Disposed | (price as of 2026-10-02) |
| May 9, 2014 | PCRX | S 10b5-1 | 20,000 | $74.08 | $1,481,600 | 0 Direct | -100.00% | Disposed | -66.0% (price as of 2026-10-02) |
| May 9, 2014 | PCRX | M | 6,836 | $5.49 | $37,530 | 20,000 Direct | +51.93% | Acquired | 359.2% (price as of 2026-10-02) |
| May 9, 2014 | PCRX | M | 13,164 | $1.61 | $21,194 | 13,164 Direct | · | Acquired | 1465.8% (price as of 2026-10-02) |
| March 11, 2014 | PCRX | J | 504 | · | · | 702 Indirect | +254.55% | Acquired | (price as of 2026-10-02) |
| Nov. 18, 2013 | PCRX | J | 83 | · | · | 198 Indirect | +72.17% | Acquired | (price as of 2026-10-02) |
| Oct. 1, 2013 | PCRX | M 10b5-1 | 20,000 | · | · | 18,084 Direct | -52.52% | Disposed | (price as of 2026-10-02) |
| Oct. 1, 2013 | PCRX | S 10b5-1 | 20,000 | $48.92 | $978,400 | 0 Direct | -100.00% | Disposed | -48.5% (price as of 2026-10-02) |
| Oct. 1, 2013 | PCRX | M 10b5-1 | 20,000 | $1.61 | $32,200 | 20,000 Direct | · | Acquired | 1465.8% (price as of 2026-10-02) |
| July 2, 2013 | PCRX | M 10b5-1 | 10,000 | · | · | 38,084 Direct | -20.80% | Disposed | (price as of 2026-10-02) |
| July 1, 2013 | PCRX | M 10b5-1 | 10,958 | · | · | 48,084 Direct | -18.56% | Disposed | (price as of 2026-10-02) |
| July 1, 2013 | PCRX | M 10b5-1 | 19,042 | · | · | 0 Direct | -100.00% | Disposed | (price as of 2026-10-02) |
Showing latest 100 of 114 transactions
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| June 3, 2026 | XENE | Restricted Share Units | Common Shares | $0.00 | · | 1,593 | Acquired |
| June 3, 2026 | XENE | Share Option (Right to Buy) | Common Shares | $53.46 | June 2, 2036 | 10,507 | Acquired |
| June 1, 2026 | XENE | Restricted Share Units | Common Shares | · | · | 2,645 | Disposed |
| June 5, 2025 | XENE | Restricted Share Units | Common Shares | $0.00 | · | 2,645 | Acquired |
| June 5, 2025 | XENE | Share Option (Right to Buy) | Common Shares | $30.73 | June 4, 2035 | 17,012 | Acquired |
| Nov. 22, 2024 | XENE | Stock Option (Right to Buy) | Common Shares | $13.48 | May 3, 2025 | 3,086 | Disposed |
| Nov. 22, 2024 | XENE | Stock Option (Right to Buy) | Common Shares | $7.38 | June 1, 2026 | 3,500 | Disposed |
| June 5, 2024 | XENE | Stock Option (Right to Buy) | Common Shares | $38.16 | June 4, 2034 | 15,542 | Acquired |
| Dec. 13, 2023 | XENE | Stock Option (Right to Buy) | Common Shares | $9.00 | Nov. 3, 2024 | 5,144 | Disposed |
| Dec. 13, 2023 | XENE | Stock Option (Right to Buy) | Common Shares | · | Jan. 13, 2024 | 2,800 | Disposed |
| Dec. 13, 2023 | XENE | Stock Option (Right to Buy) | Common Shares | · | Jan. 13, 2024 | 6,378 | Disposed |
| June 2, 2023 | XENE | Stock Option (Right to Buy) | Common Shares | $38.96 | June 1, 2033 | 18,475 | Acquired |
| Nov. 25, 2022 | XENE | Stock Option (Right to Buy) | Common Shares | · | Dec. 31, 2022 | 2,057 | Disposed |
| June 28, 2022 | XENE | Stock Option (Right to Buy) | Common Shares | $30.11 | June 27, 2032 | 18,000 | Acquired |
| Dec. 8, 2021 | XENE | Stock Option (Right to Buy) | Common Shares | · | Dec. 31, 2021 | 2,057 | Disposed |
| June 3, 2021 | XENE | Stock Option (Right to Buy) | Common Shares | $18.56 | June 2, 2031 | 10,000 | Acquired |
| Oct. 28, 2020 | XENE | Stock Option (Right to Buy) | Common Shares | · | Dec. 31, 2020 | 2,057 | Disposed |
| June 1, 2020 | XENE | Stock Option (Right to Buy) | Common Shares | $13.11 | May 31, 2030 | 10,000 | Acquired |
| Dec. 4, 2019 | XENE | Stock Option (Right to Buy) | Common Shares | · | Dec. 31, 2019 | 2,057 | Disposed |
| Sept. 16, 2019 | XENE | Stock Option (Right to Buy) | Common Shares | $9.44 | Sept. 15, 2029 | 15,000 | Acquired |
| Dec. 14, 2018 | XENE | Stock Option (Right to Buy) | Common Shares | · | Dec. 31, 2018 | 2,057 | Disposed |
| June 14, 2018 | XENE | Stock Option (Right to Buy) | Common Shares | · | June 26, 2018 | 8,230 | Disposed |
| June 4, 2018 | XENE | Stock Option (Right to Buy) | Common Shares | $6.20 | June 3, 2028 | 15,000 | Acquired |
| June 1, 2017 | XENE | Stock Option (Right to Buy) | Common Shares | $3.85 | May 31, 2027 | 3,500 | Acquired |
| Dec. 6, 2016 | XENE | Stock Option (Right to Buy) | Common Shares | · | Dec. 31, 2016 | 12,345 | Disposed |
| June 2, 2016 | XENE | Stock Option (Right to Buy) | Common Shares | $7.38 | June 1, 2026 | 3,500 | Acquired |
| Nov. 4, 2015 | XENE | Stock Option (Right to Buy) | Common Shares | · | Dec. 31, 2015 | 3,497 | Disposed |
| May 4, 2015 | XENE | Stock Option (Right to Buy) | Common Shares | · | May 3, 2025 | 3,086 | Acquired |
| Jan. 7, 2015 | XENE | Stock Option (Right to Buy) | Common Shares | · | May 8, 2015 | 3,497 | Disposed |
| Aug. 7, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $11.68 | June 7, 2022 | 3,524 | Disposed |
| Aug. 7, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $10.81 | June 5, 2022 | 14,364 | Disposed |
| Aug. 7, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $5.49 | Dec. 29, 2020 | 882 | Disposed |
| Aug. 7, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 1,230 | Disposed |
| July 14, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $10.81 | June 5, 2022 | 7,303 | Disposed |
| July 14, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $5.49 | Dec. 29, 2020 | 20,237 | Disposed |
| July 14, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 2,460 | Disposed |
| June 3, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $81.00 | June 2, 2024 | 25,000 | Acquired |
| May 12, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $5.49 | Dec. 29, 2020 | 10,000 | Disposed |
| May 9, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $5.49 | Dec. 29, 2020 | 6,836 | Disposed |
| May 9, 2014 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 13,164 | Disposed |
| Oct. 1, 2013 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 20,000 | Disposed |
| July 2, 2013 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 10,000 | Disposed |
| July 1, 2013 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 10,958 | Disposed |
| July 1, 2013 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 19,042 | Disposed |
| April 12, 2013 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 10,000 | Acquired |
| April 1, 2013 | PCRX | Stock Option (Right to Buy) | Common Stock | $1.61 | Sept. 2, 2020 | 30,000 | Acquired |
| June 7, 2012 | PCRX | Stock Option (Right to Buy) | Common Stock | $11.68 | June 7, 2022 | 60,000 | Acquired |
| June 5, 2012 | PCRX | Stock Option (Right to Buy) | Common Stock | $10.81 | June 5, 2022 | 40,000 | Acquired |
| June 5, 2012 | PCRX | Director Stock Option (Right to Buy) | Common Stock | $10.81 | June 5, 2022 | 40,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 15 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Nov. 4, 2014 | XENE | Stock Option (Right to Buy) | · | Direct |
| Feb. 2, 2011 | PCRX | Stock Option (Right to Buy) | 59,042 | Direct |
| Feb. 2, 2011 | PCRX | Stock Option (Right to Buy) | 59,042 | Direct |
| Feb. 2, 2011 | PCRX | Stock Option (Right to Buy) | 42,368 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2014 | $317,600 | $90,000 | · | $1,477,443 | · | · | · | $1,885,043 |
| 2013 | $317,600 | $50,000 | · | · | · | · | · | $367,600 |
| 2011 | $317,604 | $100,000 | · | · | · | · | $19,056 | $436,660 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.